Evidence map›Paper›PMID 29455433›Full record

ArticleMolecular and cellular biochemistry2018

Intracrine action of angiotensin II in mesangial cells: subcellular distribution of angiotensin II receptor subtypes AT

Antônio da Silva Novaes, Rosemara Silva Ribeiro, Luciana Guilhermino Pereira, Fernanda Teixeira Borges, Mirian Aparecida Boim

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. The Angiotensin ATPharmacological reviews · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Bone marrow-derived mesenchymal stromal cell: what next?Stem cells and cloning : advances and applications · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Antônio da Silva NovaesRenal Division, Department of Medicine, Federal University of São Paulo, Rua Pedro de Toledo, 781, São Paulo, SP, 04023-900, Brazil.
Rosemara Silva RibeiroRenal Division, Department of Medicine, Federal University of São Paulo, Rua Pedro de Toledo, 781, São Paulo, SP, 04023-900, Brazil.
Luciana Guilhermino PereiraRenal Division, Department of Medicine, Federal University of São Paulo, Rua Pedro de Toledo, 781, São Paulo, SP, 04023-900, Brazil.
Fernanda Teixeira BorgesRenal Division, Department of Medicine, Federal University of São Paulo, Rua Pedro de Toledo, 781, São Paulo, SP, 04023-900, Brazil.
Mirian Aparecida BoimRenal Division, Department of Medicine, Federal University of São Paulo, Rua Pedro de Toledo, 781, São Paulo, SP, 04023-900, Brazil. maboim@unifesp.br.ORCID http://orcid.org/0000-0001-7500-8371
Universidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biological effects of angiotensin II (AngII) such as regulation of AngII target genes may be triggered by interaction of AngII with intracellular AngII receptor types 1 and 2 (AT

Indexed as

Angiotensin IICell Line, TransformedHumansMesangial CellsNuclear EnvelopeReceptor, Angiotensin, Type 1Receptor, Angiotensin, Type 2AGTR1 protein, humanAngiotensin IIReceptor, Angiotensin, Type 1Receptor, Angiotensin, Type 2AT1 receptorAT2 receptorHigh glucoseIntracellular angiotensin IIMesangial cell

Identifiers

PMID29455433
OpenAlexW2794181120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.